Skip to main content

Clinical Trial Results

Search

Dr. Nihar Desai and I discuss how practice is moving toward

  1. Analyzing total plaque burden to assess risk rather focusing just on “blockages”
  2. Viewing atherosclerosis as a lifelong biological continuum focused on prevention rather than acute event centered care
  3. Viewing ACS as a failure of prevention rather than an inevitable outcome

We talk about the importance of MDs reviewing AI output and the timing of CT reassessment of risk

Sponsored by Heartflow